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Regulation of coronary vasomotion. An intact and nor- 
mally functioning endothelium is much more than a passive 
diffusion barrier: it has multiple functions that include pro- 
tection against thrombosis and a vast humoral regulatory 
function that includes production of vasorelaxing (e.g., 
endothelium-derived relaxing factor and prostacyclin) and 
vasoconstricting (e.g., endothelin) agents, production of 
growth factors and inhibitors (for endothelium and smooth 
muscle cells) and metabolism of circulating substances such 
as vasoconstrictor catecholamines and platelet products 
(l-9). 
Vasorelaxing substances are classified by their in vitro 
responses as endothelium dependent (substances that va- 
sodilate with intact and vasoconstrict with damaged endo- 
thelium) or as endothelium independent (substances that 
vasodilate with or without endothelium). Examples of the 
former include acetylcholine, adenosine diphosphate (ADP), 
serotonin, vasopressin and thrombin; these responses ap- 
pear to be mediated through the release of endothelium- 
derived relaxing factor from endothelium by these sub- 
stances but may depend on species, the specific arterial bed 
within a species and drug dosage (2-7,10,11). The vasodila- 
tion that accompanies increased blood flow and increased 
shear stress on luminal endothelial cells also appears to be 
mediated, in part, by increased basal release of endothelium- 
derived relaxing factor (12). Additional mechanisms proba- 
bly contribute to the vasodilation of normal arteries with 
exercise and include beta-adrenergic stimulation, vasodilat- 
ing metabolites and increased perfusion pressure. Endothe- 
hum-derived relaxing factor appears to cause relaxation of 
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vascular smooth muscle by way of increased production of 
cyclic guanosine 3’S’ monophosphate (GMP) and the acti- 
vation of cyclic GMP-dependent protein kinase in vascular 
smooth muscle (13). Examples of endothelium-independent 
vasodilating agents include nitroglycerin, papaverine, so- 
dium nitroprusside, adenosine and prostacyclin (6,7). How- 
ever, most of the vasoregulatory properties of endothelium 
have been evaluated in vitro. There are very few studies of 
in vivo functional responses of normal, injured or regener- 
ated endothelium. This may be studied experimentally be- 
fore and after gentle balloon injury of the endothelium or 
before and after chemical injury such as feeding cholesterol. 
Endothelial responses to acetylcholine. In vitro and in vivo 
studies in the pig show that an infusion of acetylcholine can 
distinguish normal endothelium (no change in luminal diam- 
eter) from injured or absent endothelium, which results in 
segmental vasoconstriction in the region of injury (Christi 
Ml, Lewis MJ. personal communication and 14,15). Recent 
studies from our laboratory show that regrowth of coronary 
endothelium within 1 to 2 weeks after arterial injury in the 
pig results in normalization of the response to acetylcholine 
and this can be used as an in vivo method for identifying 
normal, injured or regrown endothelium (16). The time 
course for regrowth of injured endothelium in humans is not 
known and requires further study because the endothelium 
can protect against both thrombosis and vasoconstriction. 
Coronary artery responses to endothelium-dependent in- 
tervention. The first in vivo studies in humans have shown 
minimal vasodilation in response to the infusion of acetyl- 
choline or to the cold pressor test in those with totally 
normal (smooth-walled) coronary arteries (17.18). However, 
in patients with even minimal disease in one coronary artery, 
the other smooth-walled coronary artery may respond ab- 
normally to endothelium-dependent stimuli (19-21). This 
probably relates to the fact that most risk factors for coro- 
nary disease are also injurious to the endothelium (22.23). 
This effect has been shown by studies in animals and 
suggested by studies in humans (24-26) in which a shortened 
platelet survival time increased with the reduction of risk 
factors (or substances that damage endothelium), probably 
as a result of reduced platelet-arterial wall interaction. 
Microscopic examination of the endothelium requires scan- 
ning electron microscopy for morphologic evaluation; light 
microscopy is insufficient (15,23). Macroscopic examination 
for endothelial integrity requires prior injection of Evans 
blue (stains blue with loss of integrity due to subendothelial 
protein binding) (23). Coronary angiography before and after 
endothelial-dependent intervention such as acetylcholine 
infusion or the cold pressor test, as reported in this issue of 
the Journal by Zeiher et al. (20) can now be used to assess 
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the functional integrity of the endothelium. Other endothe- 
lial-dependent interventions that result in vasodilation or 
vasoconstriction by quantitative coronary angiography, such 
as adenosine infusion or increased coronary flow with exer- 
cise, can probably also be used (21). 
The present study on in vivo coronary vasomotion. The 
study by Zeiher et al. (20) is noteworthy because it is the first 
reported comparison of the responses to an infusion of 
acetylcholine. It also the cold pressor test in the same patient 
population. It also provides improved characterization of the 
study groups by coronary risk factors (especially lipid levels) 
that may injure the endothelium. Just as the presence of 
coronary risk factors in an asymptomatic individual, perhaps 
by enhancing endothelial injury, may be associated with a 
shortened platelet survival time (24,25), such risk factors 
may also be associated with abnormal in vivo coronary 
vasomotion, which might be improved by risk factor reduc- 
tion as suggested by primate studies (27). Because the cold 
pressor response has now been shown to be a good test of 
endothelial-dependent coronary vasomotion that correlates 
with the results of acetylcholine infusion, these hypotheses 
are now more easily tested in patients. The vasomotion 
response to exercise also appears to correlate with the 
response to acetylcholine infusion (21) and thus would 
presumably also correlate with the response to the cold 
pressor test. 
Many clinical problems of unexplained ischemic pain or 
vasospasm are probably also related in part to abnormal 
endothelium, but this factor has not been fully evaluated or 
related to results of acetylcholine infusion or the cold 
pressor test. The latter two tests have also not been related 
to the more frequently used ergonovine infusion test. The 
use of the cold pressor test provides a simpler method of 
evaluating these problems in relation to abnormal endothe- 
lium and may stimulate new ways to heal injured endothe- 
lium. 
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